SLXN Stock Analysis: Buy, Sell, or Hold?
SLXN - Silexion Therapeutics Corp Ordinary Shares
$0.26
-0.02 (-6.85%)
▼
5d:
-0.15%
30d:
-26.0%
90d:
-90.88%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When SLXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SLXN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SLXN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: SLXN is currently trading at $0.26, which is considered oversold relative to its 30-day fair value range of $0.29 to $0.41.
Technical Outlook: Technically, SLXN is in a downtrend. Immediate support is located at $0.24, while resistance sits at $0.63. Short-term momentum is weak, with the stock down 6.8% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.00 (+1823.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLXN is in a downtrend. Immediate support is located at $0.24, while resistance sits at $0.63. Short-term momentum is weak, with the stock down 6.8% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.00 (+1823.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.29 -
$0.41
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BEARISH: Downward momentum (-6.8%)
- BULLISH: Trading 1823.8% below Wall St target ($5.00)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.29 -
$0.41
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.24
Resistance Level
$0.63
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.13
Wall Street Target
$5.00
(+1823.8%)
Share & Embed Analysis
Last updated: October 03, 2026 12:10 PM ET
Data refreshes hourly during market hours. Next update: 1:10 PM
Data refreshes hourly during market hours. Next update: 1:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 56 HOLD |
